Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone. [electronic resource] by
- Ocio, E M
- Fernández-Lázaro, D
- San-Segundo, L
- López-Corral, L
- Corchete, L A
- Gutiérrez, N C
- Garayoa, M
- Paíno, T
- García-Gómez, A
- Delgado, M
- Montero, J C
- Díaz-Rodríguez, E
- Mateos, M V
- Pandiella, A
- Couto, S
- Wang, M
- Bjorklund, C C
- San-Miguel, J F
Producer: 20150508
In:
Leukemia vol. 29
Availability: No items available.
|
|
30.
|
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients. [electronic resource] by
- Paiva, B
- Gutiérrez, N-C
- Chen, X
- Vídriales, M-B
- Montalbán, M-Á
- Rosiñol, L
- Oriol, A
- Martínez-López, J
- Mateos, M-V
- López-Corral, L
- Díaz-Rodríguez, E
- Pérez, J-J
- Fernández-Redondo, E
- de Arriba, F
- Palomera, L
- Bengoechea, E
- Terol, M-J
- de Paz, R
- Martin, A
- Hernández, J
- Orfao, A
- Lahuerta, J-J
- Bladé, J
- Pandiella, A
- Miguel, J-F San
Producer: 20121119
In:
Leukemia vol. 26
Availability: No items available.
|